NDUFAB1 and metabolic disease: These findings will provide the first experimental evidence establishing NDUFAB1 as both a key regulator of metabolic homeostasis and a promising therapeutic target for NEFA-associated metabolic dysfunction, advancing our understanding of periparturient metabolic disease pathogenesis.